Abstract
3,4-Dihydroquinazoline derivatives have been known to be the novel and potent T-type calcium channel blockers. From a systematic variation of 3,4-dihydroquinazoline derivative 5c (KYS05043), plausible SAR results were established. It was revealed that a 5-(dimethylamino)pentylamino group at R 1, a biphenyl group at R2, and a benzyl amido group at R3 in the 3,4-dihydroquinazoline backbone are closely related with the channel selectivity (T/N-type) as well as the potency based on the discovery of 6k (KYS05090).
| Original language | English |
|---|---|
| Pages (from-to) | 661-664 |
| Number of pages | 4 |
| Journal | Archiv der Pharmazie |
| Volume | 341 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2008 |
Keywords
- 3,4-Dihydroquinazoline
- Blockers
- SAR study
- T-type calcium channel
Fingerprint
Dive into the research topics of 'Synthesis and SAR study of T-type calcium channel blockers. Part II'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver